This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring a cyclopropylamine group and a trifluoromethylphenyl moiety, makes it valuable for developing compounds with potential biological activity. It is often explored in the design of drugs targeting central nervous system disorders, such as depression, anxiety, and neurodegenerative diseases, due to its ability to interact with specific receptors or enzymes in the brain. Additionally, it is investigated for its potential use in creating anti-inflammatory and antimicrobial agents, leveraging the trifluoromethyl group's ability to enhance metabolic stability and bioavailability. Researchers also study its role in organic synthesis for constructing complex molecules with tailored properties for industrial and therapeutic applications.